AHZANTIVE Q Code: Q5150
Injection, aflibercept-mrbb (ahzantive), biosimilar, 1 mg
Drug & Product Overview
About AHZANTIVE
Ahzantive is a medication aligned to the HCPCS Q Code: Q5150 for billing, pricing, and reimbursement purposes in the United States. This Ophthalmology medication is administered via the intravitreal route and manufactured by Formycon AG.
Manufacturers, reach out to us to add more information.
NDC Code Information
No NDC packages are aligned to Q5150 in publicly available CMS files.
| NDC Code | Drug | Manufacturer | Billing Units / Pkg | Package Size |
|---|---|---|---|---|
| No public NDC alignments | ||||
AHZANTIVE Pricing & Reimbursement
National median reimbursement across major commercial payers.
Create an account on PayerPrice for more information →
Aflibercept Biosimilar Information:
AHZANTIVE Approval Date: June 28, 2024
| Product Name | HCPCS Code | Active Ingredient | BLA Type |
|---|---|---|---|
| Eylea | J0178 | Aflibercept | 351(a) Originator Product |
| Opuviz | Q5153 | Aflibercept | 351(k) Interchangeable |
| Yesafili | Q5155 | Aflibercept | 351(k) Interchangeable |
| Ahzantive | Q5150 | Aflibercept | 351(k) Biosimilar |
| Enzeevu | Q5149 | Aflibercept | 351(k) Biosimilar |
| Pavblu | Q5147 | Aflibercept | 351(k) Biosimilar |
| Eydenzelt | Q5170 | Aflibercept | 351(k) Biosimilar |
AHZANTIVE CPT Administration Codes
The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.
| CPT Code | Description |
|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent (separate procedure) 67028 |
This product is new and does not yet appear on the CMS list of HCPCS pertaining to single-dose containers. Wastage billing guide →
AHZANTIVE Medically Unlikely Edits (MUE)
The most billing units of Q5150 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 1 mg.
MAI 2 · Date of Service Edit: Policy. Absolute per-day limit set by policy or regulation; units above it are not payable, and denials are not appealable on medical-necessity grounds. See all MUE limits →
AHZANTIVE Clinical Information
Indications and drug classification.
This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.
Login for BuyandBill.com Analytics
Unlock deeper insights with BuyandBill’s Comparative Report!
- Compare ASP, WAC, and AWP across drugs.
- Visualize Drug Price Movement Over Time
- Tailor reports to drug class, manufacturer, or HCPCS Code.
- Compare Biosimilar and 505(b)(2) products.
Frequently Asked Questions
Is there an available AHZANTIVE billing and coding guide?
Are there any available AHZANTIVE patient assistance programs?
Where can I find AHZANTIVE prescribing information?
Where can I find AHZANTIVE side effect information?
Does billing AHZANTIVE require JZ/JW wastage modifiers?
About BuyandBill.com:
The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.
Related Drug Codes
Explore billing, coding, and pricing for drugs related to AHZANTIVE.
